فهرست نشریات علمی دسترسی آزاد ایران

Background and Objectives: The diagnosis and treatment of comorbid tumors and heart disease presents significant challenges. To analyze the global research status of nuclear medicine imaging technology in patients with tumors and heart disease from 1963 to 2024, and to predict future development trends.   Methods: Relevant literature on nuclear medicine imaging technology in the field of tumors comorbid with heart disease published from 1963 to March 2024 was retrieved from the Web of Science (WoS) core database and organized using Microsoft Office Excel 2019. All studies were indexed in the SCIENCE Citation Index Expanded (SCI-EXPANDED) and Social Science Citation Index (SSCI) dataset. Literature visualization analysis was performed using VOSviewer 1.6.15 and the Bibliometrix package of R software.   Results: A total of 419 articles published between 1963 and 2024 were included in the study. The Netherlands (n=88), the United States (n=24), and the United Kingdom (n=22) were the main contributing countries in this research field. The dominance of these major contributing countries in nuclear medicine imaging research highlights their key role in fostering international collaboration on a global scale. The Journal of Nuclear Medicine was the primary source of literature, with scintigraphy (n=57), therapy (n=46), and breast cancer (n=36) being the main keywords in this field. Early studies (1963–2004) focused on scintigraphy and anthracycline-induced cardiotoxicity. Post-2005, research shifted to breast cancer and hybrid imaging (e.g., PET-CT) for therapy monitoring. 2015–2024 prioritizes cardiotoxicity (81.9% dominance), particularly linked to immunotherapies, with SPECT re-emerging for precision risk stratification.   Conclusion: Nuclear medicine techniques in the field of oncological comorbidities and chronic heart failure can guide personalised treatment.